scott solomon, md, talks heart failure drug in patients with diabetes
Published 7 years ago • 1K plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
3:07
novel strategies in type 2 diabetes and cvd
-
9:22
dr. scott solomon: dapagliflozin benefits patients with heart failure and kidney disease
-
8:28
the underappreciated burden of heart failure
-
13:17
empagliflozin in heart failure with a preserved ejection fraction
-
7:12
novel approaches in improving hf management
-
7:31
a new paradigm in heart faiure
-
10:27
paramount with dr scott solomon - trials and pis
-
6:57
how does dapagliflozin work? understanding sglt2 inhibitors.
-
19:19
diabetes and the heart. esc guidelines: part 1
-
10:31
jardiance for heart failure and diabetes: an in-depth summary
-
3:35
hf 2022: deliver extends benefits of dapagliflozin to the full spectrum of pts with hf
-
5:45
biomarkers and future strategies in heart failure
-
5:50
characteristics of patients with hfref
-
24:44
cardi-oh radio 41 - managing heart failure risk in your patient with hypertension and diabetes
-
12:49
esc tv conversations - sglt2 inhibitors – wonder drugs in heart failure and beyond?
-
6:26
consistent benefit of sacubitril/valsartan: more from paradigm-hf
-
6:04
switching hf medications in the inpatient setting
-
6:31
heart failure pathways and the role of beta blockers
-
41:04
dr. muthiah vaduganathan presents practical guide to implementation of sglt2i in clinical practice.
-
6:24
deliver results - scott d. solomon, md
-
7:05
aha 2018: declare timi-58- prof stephen d. wiviott
-
0:50
treating heart failure with golden cells™ - sonny mayo's story